| Followers | 35 |
| Posts | 1912 |
| Boards Moderated | 0 |
| Alias Born | 11/05/2020 |
Thursday, January 29, 2026 1:29:36 PM
This doesn't relieve the fact that the original patent expired years ago and that any weak "improvements" will not stop someone from creating their own that is newer, different, and/or better.
And they already have.
RadioGel wasn't the first. And they certainly aren't the last.
Hydrogels come in many different flavors. And with many different additional "add-ons" to enhance and/or supplement the gel.
The problem with sol-gels and more specifically thermogels is they don't work accordingly. It's junk science. The FDA isn't going to approve a radioactive element into a human being with a device that is insufficient.
It's not a coincidence that Fisher did the New Zealand rabbit study in 2012 and only published the bare-bones research 9 years later to make RadioGel look believable. The same year Korenko began the IDE. It's also why the FDA made them do another New Zealand rabbit study in 2023 to which the second set of rabbits were never even done. And the first were sub-clinical doses.
Krimins doesn't even acknowledge it under her name on the JHU research output page.
You gotta' wonder why both of those situations happened.
And they already have.
RadioGel wasn't the first. And they certainly aren't the last.
Hydrogels come in many different flavors. And with many different additional "add-ons" to enhance and/or supplement the gel.
The problem with sol-gels and more specifically thermogels is they don't work accordingly. It's junk science. The FDA isn't going to approve a radioactive element into a human being with a device that is insufficient.
It's not a coincidence that Fisher did the New Zealand rabbit study in 2012 and only published the bare-bones research 9 years later to make RadioGel look believable. The same year Korenko began the IDE. It's also why the FDA made them do another New Zealand rabbit study in 2023 to which the second set of rabbits were never even done. And the first were sub-clinical doses.
Krimins doesn't even acknowledge it under her name on the JHU research output page.
You gotta' wonder why both of those situations happened.
Recent RDGL News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:45:22 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:44:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
